Literature DB >> 22203034

Effects of tissue factor pathway inhibitor-2 expression on biological behavior of BeWo and JEG-3 cell lines.

Qiongjie Zhou1, Yu Xiong, Yan Chen, Yingying Du, Jin Zhang, Jingui Mu, Qisang Guo, Huijun Wang, Duan Ma, Xiaotian Li.   

Abstract

OBJECTIVES: To investigate the effect of tissue factor pathway inhibitor-2 (TFPI-2) expression on biological behavior of BeWo and JEG-3 cell lines.
MATERIAL AND METHODS: The expression of TFPI-2 in BeWo and JEG-3 cells was upregulated by pEGFP-N3-TFPI-2 and downregulated by small interference RNA transfection, confirmed by Western blotting assay and real-time polymerase chain reaction (RT-PCR). Boyden chamber, Cell Counting Kit-8 (CCK-8), and Hoechst 33258/terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) assays were used for migration, invasion, and proliferation/apoptosis analysis, respectively.
RESULTS: In Western blotting and RT-PCR assay, protein and messenger RNA (mRNA) expression of TFPI-2 in transfected BeWo and JEG-3 cells were confirmed. Expression of TFPI-2 inhibited BeWo and downregulated JEG-3 cell migration, invasion, proliferation, and induced apoptosis (P < .05) in Boyden chamber, CCK-8, Hoechst 33258, and TUNEL detection, respectively.
CONCLUSIONS: TFPI-2 expression caused invasion and proliferation impair and induced apoptosis in TFPI-2 regulated BeWo and JEG-3 cells. It provides a clue for potential role of TFPI-2 in trophoblast.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203034     DOI: 10.1177/1076029611429785

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  6 in total

1.  MiR-616-3p modulates cell proliferation and migration through targeting tissue factor pathway inhibitor 2 in preeclampsia.

Authors:  Yetao Xu; Dan Wu; Ziyan Jiang; Yuanyuan Zhang; Sailan Wang; Zhonghua Ma; Bingqing Hui; Jing Wang; Weiping Qian; Zhiping Ge; Lizhou Sun
Journal:  Cell Prolif       Date:  2018-07-20       Impact factor: 6.831

2.  Transcriptional Dynamics of Cultured Human Villous Cytotrophoblasts.

Authors:  Joshua F Robinson; Mirhan Kapidzic; Matthew Gormley; Katherine Ona; Terrence Dent; Helia Seifikar; Emily G Hamilton; Susan J Fisher
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

3.  Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.

Authors:  Marion Lavergne; Marie-Lise Jourdan; Claire Blechet; Serge Guyetant; Alain Le Pape; Nathalie Heuze-Vourc'h; Yves Courty; Stephanie Lerondel; Julien Sobilo; Sophie Iochmann; Pascale Reverdiau
Journal:  FEBS Open Bio       Date:  2013-06-27       Impact factor: 2.693

4.  Expression of tissue factor pathway inhibitor-2 in gastric stromal tumor and its clinical significance.

Authors:  Gui-Jun Wang; Yu-Bin Wang; DI-Nuo Li; Chen Li; Bei-Bei Deng
Journal:  Exp Ther Med       Date:  2013-12-13       Impact factor: 2.447

5.  S100P enhances the motility and invasion of human trophoblast cell lines.

Authors:  Maral E A Tabrizi; Tara L Lancaster; Thamir M Ismail; Athina Georgiadou; Ankana Ganguly; Jayna J Mistry; Keqing Wang; Philip S Rudland; Shakil Ahmad; Stephane R Gross
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

6.  Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.

Authors:  Yi-Hui Lai; Ru-Yin He; Jian-Liang Chou; Michael W-Y Chan; Yu-Fen Li; Chien-Kuo Tai
Journal:  J Transl Med       Date:  2014-09-02       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.